Market Cap (In INR)
14.59 Billion
Revenue (In INR)
2.08 Billion
Net Income (In INR)
224.63 Million
Avg. Volume
22.58 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 270.05-820.05
- PE
- 23.15
- EPS
- 9.5
- Beta Value
- 1.055
- ISIN
- INE048B01027
- CUSIP
- -
- CIK
- -
- Shares
- 66387100.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Manish Gupta
- Employee Count
- -
- Website
- https://www.jagsonpal.com
- Ipo Date
- 2001-11-27
- Details
- Jagsonpal Pharmaceuticals Limited engages in the manufacture and trading of pharmaceutical products and active pharmaceutical ingredients in the areas in the areas of women health, pain and analgesics, and general medicine in India and internationally. It offers pharmaceutical formulations and over the counter drugs in the areas of gynaecology, orthopaedics, and allergy management. It offers drugs in the form of tablets, softgels, injections, capsules, and syrups. The company was incorporated in 1978 and is headquartered in New Delhi, India.
More Stocks
-
6262
-
WEWINWe Win Limited
WEWIN
-
IG6
-
ALGWFAlliance Growers Corp.
ALGWF
-
300042Netac Technology Co., Ltd.
300042
-
INNOCORPInnocorp Limited
INNOCORP
-
PLLTLPiedmont Lithium Inc.
PLLTL
-
SEMAC